The Incidence of End-Stage Renal Disease Is Increasing Faster than the Prevalence of Chronic Renal Insufficiency
Top Cited Papers
- 20 July 2004
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 141 (2) , 95-101
- https://doi.org/10.7326/0003-4819-141-2-200407200-00007
Abstract
The steady increase in end-stage renal disease (ESRD) incidence is a worldwide public health crisis. To determine whether the increasing incidence of ESRD in the United States is preceded by increased prevalence of chronic renal insufficiency. Birth cohort analysis. Nationally representative Second and Third National Health and Nutrition Examination Surveys (NHANES II [1976–1980] and III [1988–1994]) and nationally comprehensive U.S. Renal Data System registry. Adults, 20 to 74 years of age, surveyed in NHANES II (midpoint, 1978) and NHANES III (midpoint, 1991), and adults, 25 to 79 years of age, who developed ESRD in 1983 and 1996. Prevalent chronic renal insufficiency (estimated glomerular filtration rate, 15 to 59 mL/min per 1.73 m2) and new ESRD cases. From 1978 to 1991, the number of adults age 20 to 74 years with chronic renal insufficiency increased from 2.6 to 3.9 million, an increase in prevalence from 1970 to 2460 per 100 000 persons. However, the increased incidence of ESRD was even greater during this period. For every 1000 adults with chronic renal insufficiency in 1978, 9 new cases of ESRD developed in 1983, but every 1000 adults with chronic renal insufficiency in 1991 produced 16 new cases of ESRD in 1996 (relative risk, 1.7 [95% CI, 1.1 to 2.7]). We could not follow individual patients with chronic renal insufficiency for the development of ESRD, and we used estimated rather than measured glomerular filtration rate. During the period examined, growth in incident ESRD outpaced growth in prevalent chronic renal insufficiency, demonstrating that the ESRD epidemic in the United States is not merely a function of more cases of kidney disease. Future research should examine other potential contributors to ESRD growth, such as improved survival from nonrenal diseases and more liberal entry into treatment programs.Keywords
This publication has 14 references indexed in Scilit:
- Racial Differences in the Progression from Chronic Renal Insufficiency to End-Stage Renal Disease in the United StatesJournal of the American Society of Nephrology, 2003
- The Contribution of Increased Diabetes Prevalence and Improved Myocardial Infarction and Stroke Survival to the Increase in Treated End-Stage Renal DiseaseJournal of the American Society of Nephrology, 2003
- Excerpts From the United States Renal Data System 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United StatesAmerican Journal of Kidney Diseases, 2003
- Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rateAmerican Journal of Kidney Diseases, 2002
- Prevalence of High Blood Pressure and Elevated Serum Creatinine Level in the United StatesArchives of internal medicine (1960), 2001
- II. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: Update 2000American Journal of Kidney Diseases, 2001
- Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994Diabetes Care, 1998
- NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacyAmerican Journal of Kidney Diseases, 1997
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- CLINICAL CALORIMETRYArchives of internal medicine (1908), 1916